H. Swayze

A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed Ina CTivated infl Uenza vaccine in adult S aged 65 years and above (INVICTUS): a study protocol

C. Butler, Ly-Mee Yu, A. Hill, 2019, F1000Research.

Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study

Jonathan R. Crawshaw, T. Blakeman, C. Chew‐Graham, 2021, ESC Heart Failure.

Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS)

Ly-Mee Yu, A. Lawrie, M. Shanyinde, 2021, Vaccines.

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

H. Jessen, M. Pangalos, R. Fischer, 2022, The Lancet Respiratory Medicine.

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk

S. de Lusignan, F. Hobbs, C. Butler, 2021, BMJ Open.

A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed Ina CTivated infl Uenza vaccine in adult S aged 65 years and above (INVICTUS): a study protocol

C. Butler, Ly-Mee Yu, A. Hill, 2019, F1000Research.